About Us



Victoria Cruz and Rolf Brekken

Victoria Cruz (Burton)

Ph.D., Cancer Biology
Thesis: Loss of TBK1 kinase function improves disease outcome in pancreatic cancer and metabolic syndrome 



Rolf Brekken and Mary Topalovski

Mary Topalovski

Ph.D., Cancer Biology
Thesis: Fibulin-5 promotes pancreatic tumor growth through inhibition of integrin-induced ROS
Currently a postdoctoral fellow at UCSD. 



Rolf Brekken and Kristina Aguilera

Kristina Aguilera

Ph.D., Cancer Biology
Thesis: Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-Mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma
Currently Scientist at BerGenBio, Bergen, Norway. 



Kristi Lynn, Rolf Brekken and Laura Sullivan

Kristi Lynn

Ph.D., Cancer Biology
Thesis: Anti-VEGF Therapy Modulates Immune Cell Infiltration and Function in Multiple Breast Cancer Models
Currently a technology analyst  at the Technology Transfer office at UT Southwestern.

Laura Sullivan

Ph.D., Cancer Biology
Thesis: Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer: Characterizing a New Therapy and Investigating Potential Mechanisms of Resistance
Currently a consultant/analyst for ClearView Healthcare Partners, Newton, Mass.



Rolf Brekken and Marie Schluterman

Marie Schluterman

Ph.D., Integrative Biology
Thesis: Novel Function for Fibulin-5 in Controlling Integrin-Induced ROS Production: Implications on Angiogenesis and Cancer
Currently a postdoctoral fellow at University of Arkansas for Medical Sciences, Little Rock, Ark. 

Lee Rivera

Ph.D., Cell Regulation
Thesis: Regulation of Pericyte Behavior by Secreted Protein Acidic and Rich in Cysteine
Currently a postdoctoral fellow at UC San Francisco.



Shanna Arnold

Ph.D., Integrative Biology
Thesis: SPARC: a Matricellular Regulator of the Tumor Microenvironment
Currently a postdoctoral fellow at Vanderbilt University.